-
Sponsor:
FACT-ES - Functional Assessment of Cancer Therapy - Endocrine Symptoms
An 18 item endocrine subscale (ES) to accompany a standardised breast cancer quality of life measure, the Functional Assessment of Cancer Therapy (FACT-B), to measure the side effects and putative benefits of hormonal treatments given in breast cancer. Available from FACIT.Related Publication
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the FACT-B Find it online hereRelated Publication
Quality of Life in the Intergroup Exemestane Study: A Randomized Trial of Exemestane Versus Continued Tamoxifen After 2 to 3 Years of Tamoxifen in Postmenopausal Women With Primary Breast Cancer Find it online here
EMAIL: adminshore-c@sussex.ac.uk
PHONE: 01273 873019
TWITTER: https://twitter.com/SussexSHORE_C
LOCATION: MAP